XML 46 R31.htm IDEA: XBRL DOCUMENT v3.19.2
Segment Information (Tables)
9 Months Ended
Jun. 28, 2019
Segment Reporting [Abstract]  
Schedule of Total Revenues, Segment Operating Profit and Total Asset for Reporting Segment
The following tables present total revenues and segment operating profit from continuing operations for each reportable segment (in thousands) and includes a reconciliation of segment operating profit to total U.S. GAAP operating profit by including certain corporate-level expenses, Restructuring and other charges and transaction and integration costs (in thousands). Prior period information has been recast to reflect the current period presentation.
 
For the Three Months Ended
 
For the Nine Months Ended
 
June 28, 2019
 
June 29, 2018
 
June 28, 2019
 
June 29, 2018
Revenues from External Customers:
 
 
 
 
 
 
 
Aerospace, Technology and Nuclear
$
1,156,488

 
$
1,021,523

 
$
3,251,024

 
$
2,656,303

Buildings, Infrastructure and Advanced Facilities
2,013,134

 
1,912,100

 
6,093,981

 
4,931,613

              Total
$
3,169,622

 
$
2,933,623

 
$
9,345,005

 
$
7,587,916

 
For the Three Months Ended
 
For the Nine Months Ended
 
June 28, 2019
 
June 29, 2018
 
June 28, 2019
 
June 29, 2018
Segment Operating Profit:
 
 
 
 
 
 
 
Aerospace, Technology and Nuclear
$
76,306

 
$
69,085

 
$
222,289

 
$
182,609

Buildings, Infrastructure and Advanced Facilities
183,318

 
163,193

 
515,465

 
374,809

Total Segment Operating Profit
259,624

 
232,278

 
737,754

 
557,418

Other Corporate Expenses (1)
(64,525
)
 
(34,802
)
 
(185,674
)
 
(131,163
)
Restructuring and Other Charges
(92,407
)
 
(30,544
)
 
(233,579
)
 
(122,744
)
Transaction Costs
(12,738
)
 
(4,420
)
 
(12,738
)
 
(76,915
)
Total U.S. GAAP Operating Profit
89,954

 
162,512

 
305,763

 
226,596

Total Other (Expense) Income, net (2)
3,445

 
(15,879
)
 
(8,344
)
 
(38,016
)
Earnings from Continuing Operations Before Taxes
$
93,399

 
$
146,633

 
$
297,419

 
$
188,580

(1)
Other corporate expenses include costs that were previously allocated to the ECR segment prior to discontinued operations presentation in connection with the ECR sale in the approximate amounts of $2.0 million and $6.4 million for the three-month periods ended June 28, 2019 and June 29, 2018, respectively, and $14.8 million and $19.2 million for the nine-month periods ended June 28, 2019 and June 29, 2018, respectively. Other corporate expenses also include intangibles amortization of $18.4 million and $19.3 million for the three-month periods ended June 28, 2019 and June 29, 2018, respectively, and $55.7 million and $49.1 million for the nine-month periods ended June 28, 2019 and June 29, 2018, respectively.
(2)
Includes gain on the settlement of the CH2M retiree medical plans of $0.0 million and $34.6 million, respectively, and the amortization of deferred financing fees related to the CH2M acquisition of $0.5 million and $1.5 million, respectively, for the three- and nine-month periods ended June 28, 2019, as well as amortization of deferred financing fees related to the CH2M acquisition of $0.5 million and $1.2 million, respectively, for the three- and nine-month periods ended June 29, 2018. Also includes revenues under the Company's TSA agreement with WorleyParsons of $14.1 million, respectively, for the three- and nine-month periods ended June 28, 2019, for which the related costs are included in SG&A.